CD274 and gastric cancer: The immune regulatory PD-1/PD-L1 axis can induce inhibitory immune signaling within activated T cells, destroying their antitumor immune response, and thus is an immune checkpoint target for immunotherapy in many malignancies including GC (4, 7).